Increased expression of COX2 in NASH-HCC mice was inhibited by berberine, possibly because berberine inhibits inflammation and angiogenesis via the p38MAPK/ERK-COX2 pathway (Luo Y. et al., 2019). Here, PTGS2 is linked to metabolic dysfunction-associated steatohepatitis.